MENÚ
AR | ARS
AR | ARS
-
- Pipeteo manual & dispensación
- Pipetas mecánicas
- Pipetas electrónicas
- Pipetas multicanal
- Pipetas de desplazamiento positivo y dispensadores
- Pipeteo automatizado
- Dispensadores de botella
- Controladores de pipeta
- Puntas de pipeta
- Consumibles de automatización
- Accesorios para dispensadores y pipetas
- Accesorios de automatización
- Servicios para dispensadores y pipetas
Está a punto de abandonar este sitio.
Por favor, tenga en cuenta que su carro de la compra actual no ha sido guardado todavía y no podrá ser restablecido en el nuevo sitio ni cuando regrese. Si desea guardar su carro de la compra, inicie sesión en su cuenta.
Sorry, we couldn't find anything on our website containing your search term.
Webinar
Breaking Boundaries in Process Development: Unleashing the Power of Stirred-Tank Bioreactors for Cell and Gene Therapies
Academia de laboratorio
- Bioprocesamiento
- Vida en el laboratorio
- Bioproceso
- Webinarios grabados
The field of cell and gene therapy has enjoyed spectacular growth in recent years and is destined to be one of the strongest growing markets in the biopharmaceutical industry. More than 20 approved gene therapies are already on the market, providing potentially life-saving treatment options for patients with rare diseases. Manufacturing these novel therapies requires a continual supply of billions of cells, generated by robust, scalable, and economically viable bioprocesses.
In this regard, stirred-tank bioreactors have emerged as the optimal platform to optimize (stem) cell culturing to optimize process development. While facing similar challenges as encountered by the traditional biologics industry, the cell and gene therapy industry can benefit from those lessons. This community will benefit from the successful transfer of knowledge and best practices in terms of scalability, single-use technologies, and the overall benefits of moving to stirred-tank bioreactor systems. In this webinar, experts from industry and academia will share their insights and experiences as they lay out the potential of stirred-tank bioreactors for cell and gene therapy development and manufacturing.
Key Learning Objectives:
Speakers:
Dr. Philipp Nold, Eppendorf SE
Dr. Robert Zweigerdt, MHH
Lior Raviv, Pluri Inc.
Duration:
90 min
Register in the form below.
Key Learning Objectives:
- Advances in commercializing cell and gene therapy development
- The key role of stirred-tank bioreactors from research to manufacturing
- How to bring life-saving cell and gene therapies to market
Speakers:
Dr. Philipp Nold, Eppendorf SE
Dr. Robert Zweigerdt, MHH
Lior Raviv, Pluri Inc.
Duration:
90 min
Register in the form below.
Leer más
Leer menos